Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.
AUTOR(ES)
Sfikakis, P P
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=170511Documentos Relacionados
- Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study
- Hypergammaglobulinaemia and autoimmune rheumatic diseases.
- Hepatitis B virus infection in patients with rheumatic diseases.
- Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris
- Amyloidosis in the rheumatic diseases.